Table: Kaken Pharmaceutical - 6-MTH group results

KAKEN PHARMACEUTICAL

10/11/2025 06:31

Nov 10 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2025        Sep 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             39.36               51.37            86.30    
                 (-23.4 pct)         (+42.0 pct)      (-8.2 pct)  
  Operating        203 mln              19.58             2.10    
                 (-99.0 pct)        (+255.2 pct)      (-90.0 pct) 
  Recurring        607 mln              19.82             2.80    
                 (-96.9 pct)        (+246.4 pct)      (-86.8 pct) 
  Net              992 mln              14.29             2.30    
                 (-93.0 pct)        (+251.2 pct)      (-83.5 pct) 
  EPS             26.16 yen          377.23 yen        60.74 yen  
  Ann Div                            190.00 yen       190.00 yen  
  -Q2 div         95.00 yen          115.00 yen                   
  -Q4 div                             75.00 yen        95.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T